The platform's sensitivity in detecting tumour cells stood at 80%, compared to 29% for CSF cytology. Additionally, CNSide detected actionable mutations such as the amplification of human epidermal ...

The inclusion criteria were age ≥18 years at cancer diagnosis, pathologically confirmed solid tumor, CNSms confirmed with computed tomography, MRI, or positive cerebrospinal fluid cytology. The ...